{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:42Z","timestamp":1792153242617,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/ncprheum0436","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T20:46:46Z","timestamp":1172868406000},"page":"148-155","source":"Crossref","is-referenced-by-count":241,"title":["Beh\u00e7et's syndrome: disease manifestations, management, and advances in treatment"],"prefix":"10.1038","volume":"3","author":[{"given":"Hasan","family":"Yazici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzet","family":"Fresko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebahattin","family":"Yurdakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum0436_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"41","author":"T Sakane","year":"1999","unstructured":"Sakane T et al. (1999) Behcet's disease N Engl J Med 41:1284\u20131291","journal-title":"N Engl J Med"},{"key":"BFncprheum0436_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"G Azizlerli","year":"2003","unstructured":"Azizlerli G et al. (2003) Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol 42: 803\u2013806","journal-title":"Int J Dermatol"},{"key":"BFncprheum0436_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","volume":"132","author":"I Kone-Paut","year":"1998","unstructured":"Kone-Paut I et al. (1998) Clinical features of Behcet's disease in children: an international collaborative study of 86 cases. J Pediatr 132: 721\u2013725","journal-title":"J Pediatr"},{"key":"BFncprheum0436_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ard.55.3.208","volume":"55","author":"S Yurdakul","year":"1996","unstructured":"Yurdakul S et al. (1996) Gastrointestinal involvement in Behcet's syndrome: a controlled study. Ann Rheum Dis 55: 208\u2013210","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/ard.43.1.74","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H et al. (1984) A comparative study of the pathergy reaction among Turkish and British patients with Behcet's disease. Ann Rheum Dis 43: 74\u201375","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0738-081X(99)00013-9","volume":"17","author":"T Saylan","year":"1999","unstructured":"Saylan T et al. (1999). Behcet's disease in the Middle East. Clinical Dermatol 17: 209\u2013223","journal-title":"Clinical Dermatol"},{"key":"BFncprheum0436_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1365-4632.2006.02859.x","volume":"45","author":"CM Mat","year":"2006","unstructured":"Mat CM et al. (2006) The frequency of scarring after genital ulcers in Behcet's syndrome: a prospective study. Inter J Dermatol 45: 554\u2013556","journal-title":"Inter J Dermatol"},{"key":"BFncprheum0436_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1365-4362.1998.00276.x","volume":"37","author":"T Ergun","year":"1998","unstructured":"Ergun T et al. (1998) Histopathologic features of the spontaneous pustular lesions of Behcet's syndrome. Int J Dermatol 37: 194\u2013196","journal-title":"Int J Dermatol"},{"key":"BFncprheum0436_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555597779","volume":"59","author":"Y T\u00fcz\u00fcn","year":"1979","unstructured":"T\u00fcz\u00fcn Y et al. (1979) The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behcet's disease in Turkey. Acta Derm Venerol 59: 77\u201379","journal-title":"Acta Derm Venerol"},{"key":"BFncprheum0436_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I et al. (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138: 373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"BFncprheum0436_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/ard.42.5.505","volume":"42","author":"S Yurdakul","year":"1983","unstructured":"Yurdakul S et al. (1983) The arthritis of Behcet's disease: a prospective study. Ann Rheum Dis 42: 505\u2013515","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/ard.40.6.558","volume":"40","author":"H Yazici","year":"1981","unstructured":"Yazici H et al. (1981) A controlled survey of sacroiliitis in Behcet's disease. Ann Rheum Dis 40: 558\u2013559","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","volume":"60","author":"E Diri","year":"2001","unstructured":"Diri E et al. (2001) Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60: 1074\u20131076","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR14","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G et al. (1999) Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. Brain 122: 2171\u20132182","journal-title":"Brain"},{"key":"BFncprheum0436_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A et al. (2001) Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248: 95\u2013103","journal-title":"J Neurol"},{"key":"BFncprheum0436_CR16","first-page":"402","volume":"19","author":"Y Koc","year":"1992","unstructured":"Koc Y et al. (1992) Vascular involvement in Behcet's disease. J Rheumatol 19: 402\u2013410","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR17","first-page":"341","volume":"19","author":"JT Lie","year":"1992","unstructured":"Lie JT (1992) Vascular involvement in Behcet's disease: arterial and venous and vessels of all sizes. J Rheumatol 19: 341\u2013343","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","volume":"117","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan V et al. (2004) Pulmonary artery aneurysms in Behcet syndrome. Am J Med 117: 867\u2013870","journal-title":"Am J Med"},{"key":"BFncprheum0436_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00261-002-0036-0","volume":"28","author":"U Korman","year":"2003","unstructured":"Korman U et al. (2003) Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease. Abdom Imaging 28: 308\u2013312","journal-title":"Abdom Imaging"},{"key":"BFncprheum0436_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1346-8138.1990.tb01653.x","volume":"17","author":"SI Chun","year":"1990","unstructured":"Chun SI et al. (1990) Histopathology of cutaneous lesions in Behcet's syndrome. J Dermatol 17: 333\u2013341","journal-title":"J Dermatol"},{"key":"BFncprheum0436_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1309\/GCTH-0060-55K8-XCTT","volume":"116","author":"C Demirkesen","year":"2001","unstructured":"Demirkesen C et al. (2001) Clinicopathologic evaluation of nodular cutaneous lesions of Behcet syndrome. Am J Clin Pathol 116: 341\u2013346","journal-title":"Am J Clin Pathol"},{"key":"BFncprheum0436_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0046-8177(91)90060-3","volume":"22","author":"T Matsumoto","year":"1991","unstructured":"Matsumoto T et al. (1991) Vasculo-Behcet's disease: a pathologic study of eight cases. Hum Pathol 22: 45\u201351","journal-title":"Hum Pathol"},{"key":"BFncprheum0436_CR23","first-page":"55","volume":"16","author":"MG Hadfield","year":"1997","unstructured":"Hadfield MG et al. (1997) Neuro-Behcet's disease. Clin Neuropathol 16: 55\u201360","journal-title":"Clin Neuropathol"},{"key":"BFncprheum0436_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/08830189709116846","volume":"14","author":"GE Ehrlich","year":"1997","unstructured":"Ehrlich GE (1997) Vasculitis in Behcet's disease. Int Rev Immunol 14: 81\u201388","journal-title":"Int Rev Immunol"},{"key":"BFncprheum0436_CR25","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL et al. (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20: 1544\u20131549","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR26","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"M Ben Ahmed","year":"2004","unstructured":"Ben Ahmed M et al. (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease. Arthritis Rheum 50: 2291\u20132295","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR27","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","volume":"42","author":"MA Frassanito","year":"1999","unstructured":"Frassanito MA et al. (1999) TH1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42: 1967\u20131974","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR28","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.4049\/jimmunol.177.9.6415","volume":"177","author":"M Melikoglu","year":"2006","unstructured":"Melikoglu M et al. (2006) Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J Immunol 177: 6415\u20136421","journal-title":"J Immunol"},{"key":"BFncprheum0436_CR29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.11074","volume":"48","author":"KH Lee","year":"2003","unstructured":"Lee KH et al. (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 48: 2025\u20132035","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","volume":"112","author":"G Espinosa","year":"2002","unstructured":"Espinosa G et al. (2002) Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112: 37\u201343","journal-title":"Am J Med"},{"issue":"Suppl 38","key":"BFncprheum0436_CR31","first-page":"S53","volume":"23","author":"S Yurdakul","year":"2005","unstructured":"Yurdakul S et al. (2005) Fibrinolytic activity and d-dimer levels in Behcet's syndrome. Clin Exp Rheumatol 23 (Suppl 38): S53\u2013S58","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0436_CR32","first-page":"2393","volume":"29","author":"R Tunc","year":"2002","unstructured":"Tunc R et al. (2002) Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29: 2393\u20132396","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR33","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/ard.2003.017467","volume":"63","author":"G Hatemi","year":"2004","unstructured":"Hatemi G et al. (2004) The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 63: 1450\u20131452","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 38","key":"BFncprheum0436_CR34","first-page":"S67","volume":"23","author":"I Fresko","year":"2005","unstructured":"Fresko I et al. (2005) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome. Clin Exp Rheumatol 23 (Suppl 38): S67\u2013S70","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0436_CR35","first-page":"347","volume":"17","author":"I Krause","year":"1999","unstructured":"Krause I et al. (1999) Disease patterns of patients with Behcet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17: 347\u2013350","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0436_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/ard.2003.018515","volume":"63","author":"R Tunc","year":"2004","unstructured":"Tunc R et al. (2004) Cerebral venous thrombosis is associated with major vessel disease in Behcet's syndrome. Ann Rheum Dis 63: 1693\u20131694","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"A Gul","year":"2005","unstructured":"Gul A (2005) Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4: 81\u201383","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"Suppl 38","key":"BFncprheum0436_CR38","first-page":"S1","volume":"23","author":"H Yazici","year":"2005","unstructured":"Yazici H and Fresko I (2005) Behcet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23 (Suppl 38): S1\u2013S2","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0436_CR39","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/1529-0131(200111)44:11<2693::AID-ART449>3.0.CO;2-M","volume":"44","author":"A Gul","year":"2001","unstructured":"Gul A et al. (2001) Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22\u201323. Arthritis Rheum 44: 2693\u20132696","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/ard.57.1.45","volume":"57","author":"I Fresko","year":"1998","unstructured":"Fresko I et al. (1998) Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 57: 45\u201348","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0436_CR41","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/art.21060","volume":"52","author":"J Karasneh","year":"2005","unstructured":"Karasneh J et al. (2005) Whole-genome screening for susceptibility genes in multicase families with Beh\u00e7et's disease. Arthritis Rheum 52: 1836\u20131842","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.a.20136","volume":"122","author":"N Molinari","year":"2003","unstructured":"Molinari N et al (2003) Identification of an autosomal recessive mode of inheritance in paediatric Behcet's families by segregation analysis. Am J Med Genet 122: 115\u2013118","journal-title":"Am J Med Genet"},{"key":"BFncprheum0436_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/rheumatology\/keh063","volume":"43","author":"G Saruhan-Direskeneli","year":"2004","unstructured":"Saruhan-Direskeneli G et al. (2004) Expression of KIR and C-type lectin receptors in Beh\u00e7et's disease. Rheumatology (Oxford) 43: 423\u2013427","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0436_CR44","first-page":"287","volume":"32","author":"N Inanc","year":"2005","unstructured":"Inanc N et al. (2005) Serum mannose-binding lectin levels are decreased in Behcet's disease and associated with disease severity. J Rheumatol 32: 287\u2013291","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E et al. (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82: 60\u201376","journal-title":"Medicine (Baltimore)"},{"key":"BFncprheum0436_CR46","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/rheumatology\/keh359","volume":"43","author":"E Seyahi","year":"2004","unstructured":"Seyahi E et al. (2004) Coronary atherosclerosis in Behcet's syndrome: a pilot study using electron-beam computed tomography. Rheumatology (Oxford) 43: 1448\u20131450","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0436_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan V et al. (1997) Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 40: 69\u201374","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","volume":"45","author":"C Mat","year":"2006","unstructured":"Mat C et al. (2006) Double-blind trial of depot corticosteroids in Behcet's syndrome. Rheumatology (Oxford) 45: 348\u2013352","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0436_CR49","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu M et al. (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32: 98\u2013105","journal-title":"J Rheumatol"},{"key":"BFncprheum0436_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E Alpsoy","year":"2002","unstructured":"Alpsoy E et al. (2002) Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol 138: 467\u2013471","journal-title":"Arch Dermatol"},{"key":"BFncprheum0436_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","volume":"29","author":"KE Sharquie","year":"2002","unstructured":"Sharquie KE et al. (2002) Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study. J Dermatol 29: 267\u2013279","journal-title":"J Dermatol"},{"key":"BFncprheum0436_CR52","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","volume":"44","author":"S Yurdakul","year":"2001","unstructured":"Yurdakul S et al. (2001) Double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum 44: 2686\u20132692","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan V et al. (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128: 443\u2013450","journal-title":"Ann Intern Med"},{"key":"BFncprheum0436_CR54","first-page":"493","volume":"13","author":"F Moral","year":"1995","unstructured":"Moral F et al. (1995) Inefficacy of azapropazone in the acute arthritis of Behcet's syndrome: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 13: 493\u2013495","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0436_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H et al. (1990) A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 322: 281\u2013285","journal-title":"N Engl J Med"},{"key":"BFncprheum0436_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","volume":"1","author":"K Masuda","year":"1989","unstructured":"Masuda K et al. (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 1: 1093\u20131096","journal-title":"Lancet"},{"key":"BFncprheum0436_CR57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","volume":"27","author":"UM Davies","year":"1988","unstructured":"Davies UM et al. (1988) Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial. Br J Rheumatol 27: 300\u2013302","journal-title":"Br J Rheumatol"},{"key":"BFncprheum0436_CR58","first-page":"399","volume":"65","author":"E Aktulga","year":"1980","unstructured":"Aktulga E et al. (1980) A double blind study of colchicine in Behcet's disease. Haematologica 65: 399\u2013402","journal-title":"Haematologica"},{"key":"BFncprheum0436_CR59","first-page":"227","volume-title":"Behcet's Syndrome","author":"AM Denman","year":"1979","unstructured":"Denman AM et al. (1979) Failure of transfer factor in the treatment of Behcet's syndrome: a double-blind trial. In Behcet's Syndrome, 227\u2013289 (Eds Lehner T and Barnes CG) London: Academic Press"},{"key":"BFncprheum0436_CR60","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","volume":"33","author":"I Kotter","year":"2004","unstructured":"Kotter I et al. (2004) The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 33: 320\u2013335","journal-title":"Semin Arthritis Rheum"},{"key":"BFncprheum0436_CR61","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.21231","volume":"52","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I et al. (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial. Arthritis Rheum 52: 2478\u20132484","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0436_CR62","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno S et al. (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J Rheumatol 31: 1362\u20131368","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"BFncprheum0436_CR63","first-page":"S385","volume":"48","author":"O Kahraman","year":"2003","unstructured":"Kahraman O et al. (2003) Long-term course of deep venous trombosis in patients with Behcet's disease [abstract]. Arthritis Rheum 48 (Suppl): S385","journal-title":"Arthritis Rheum"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0436","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T10:36:29Z","timestamp":1707647789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BFncprheum0436"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0436","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}